ATP5F1B plays a beneficial role in obesity-induced non-alcoholic fatty liver disease (NAFLD) by improving mitochondrial function in hepatic steatosis [37]. The gene discussed is ATP5F1B; the disease is metabolic dysfunction-associated steatotic liver disease.